LCAT and hyperlipidemia: NKT treatment appears to regulate the synthesis of cholesterol by inhibiting the activity of HMG-CoA-R and by enhancing the HDL cholesterol turnover through increasing the activity of LCAT in ISO-triggered hyperlipidemia in rats, which is suggestive of the antihyperlipidemic property of NKT.